Patients who took Ozempic 2.0 in clinical trial reveal its staggering results... and terrifying side effects
Pharma giant Novo Nordisk, the company behind Wegovy and Ozempic, expects to launch six products in the next five years. Leading the pack of new drugs will be CagriSema.
Malaysian Reserve8h
Ozempic: From diabetes treatment to weight loss trend
Ozempic is traditionally used as a treatment for type 2 diabetes (T2DM) to help patients manage blood sugar levels. However, ...
Is Compounded Semaglutide Effective for Weight Loss?
Is compounded semaglutide effective for weight loss? Here’s the short version: Compounded semaglutide isn’t approved by the ...
Looking to buy weight-loss jabs? You need to pass more checks from now on
New industry rules require visual size checks or GP medical records for online fat jab purchases. The updated guidelines ...
Michael ‘Wippa’ Wipfli: Nova radio host admits to using pricey weight loss drug Mounjaro
A Nova radio host has admitted live on-air to taking a weight loss drug popular with celebrities that costs an arm and a leg ...
Healthy Returns: Why people quit weight loss, diabetes drugs within one year
A new study examines how cost, side effects, and other factors influence whether people stop GLP-1s, while Noom cuts staff to ...
The end of needles: So many people can't take weight-loss jabs or vital medicines because they're scared of injections. Now there's an astonishing new treatment, doc…
One in ten people in the UK have a needle phobia so serious it means they frequently miss out on vital treatments such as ...
Investors are growing anxious about Novo Nordisk’s silence since disappointing CagriSema weight loss drug results
Investors are upset at a lack of clarity over the results of Wegovy successor CagriSema after trials published in December.
Ozempic is tearing our friendship group apart after our body-positive pal started taking it
As warnings are issued over weight loss medication being too easy to buy online, here is one cautionary tale of how it can be ...
Here's why researchers think most people stop taking weight loss drugs within a year
Nearly 2 in 3 people without diabetes quit popular weight loss drugs such as Ozempic or Victoza within one year, according to a new study.
Researchers probe potential role of Ozempic, other weight-loss drugs in vision loss
Physician–scientists at the University of Utah's John A. Moran Eye Center have published an investigatory review of nine patients who experienced vision complications while taking popular semaglutide ...